EIF4E and lung carcinoma: Lung cancer patients with higher exosomal eIF4E expression were more likely to present distant metastasis, advanced TNM stage, and serum positive cytokeratin fragment 19 (CYFRA21-1), and exosomal eIF4E was also determined to be an independent prognostic factor for shorter OS and progression-free survival [111].